rs41285288

Variant summary

Our verdict is Benign. The variant received -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBS1BS2

The NM_000426.4(LAMA2):​c.4437-5T>A variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00821 in 1,611,536 control chromosomes in the GnomAD database, including 78 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0055 ( 5 hom., cov: 32)
Exomes 𝑓: 0.0085 ( 73 hom. )

Consequence

LAMA2
NM_000426.4 splice_region, intron

Scores

2
Splicing: ADA: 0.8827
2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:13

Conservation

PhyloP100: 1.73

Publications

5 publications found
Variant links:
Genes affected
LAMA2 (HGNC:6482): (laminin subunit alpha 2) Laminin, an extracellular protein, is a major component of the basement membrane. It is thought to mediate the attachment, migration, and organization of cells into tissues during embryonic development by interacting with other extracellular matrix components. It is composed of three subunits, alpha, beta, and gamma, which are bound to each other by disulfide bonds into a cross-shaped molecule. This gene encodes the alpha 2 chain, which constitutes one of the subunits of laminin 2 (merosin) and laminin 4 (s-merosin). Mutations in this gene have been identified as the cause of congenital merosin-deficient muscular dystrophy. Two transcript variants encoding different proteins have been found for this gene. [provided by RefSeq, Jul 2008]
LAMA2 Gene-Disease associations (from GenCC):
  • congenital merosin-deficient muscular dystrophy 1A
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, G2P, Myriad Women’s Health
  • LAMA2-related muscular dystrophy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • muscular dystrophy, limb-girdle, autosomal recessive 23
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -18 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.46).
BP6
Variant 6-129349293-T-A is Benign according to our data. Variant chr6-129349293-T-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 92958.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00547 (833/152300) while in subpopulation NFE AF = 0.00866 (589/68028). AF 95% confidence interval is 0.00808. There are 5 homozygotes in GnomAd4. There are 377 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 5 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000426.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LAMA2
NM_000426.4
MANE Select
c.4437-5T>A
splice_region intron
N/ANP_000417.3
LAMA2
NM_001079823.2
c.4437-5T>A
splice_region intron
N/ANP_001073291.2A0A087WYF1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LAMA2
ENST00000421865.3
TSL:5 MANE Select
c.4437-5T>A
splice_region intron
N/AENSP00000400365.2P24043
LAMA2
ENST00000618192.5
TSL:5
c.4701-5T>A
splice_region intron
N/AENSP00000480802.2A0A087WX80
LAMA2
ENST00000617695.5
TSL:5
c.4437-5T>A
splice_region intron
N/AENSP00000481744.2A0A087WYF1

Frequencies

GnomAD3 genomes
AF:
0.00549
AC:
835
AN:
152182
Hom.:
5
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00220
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00314
Gnomad ASJ
AF:
0.0127
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00290
Gnomad FIN
AF:
0.00254
Gnomad MID
AF:
0.0190
Gnomad NFE
AF:
0.00866
Gnomad OTH
AF:
0.00765
GnomAD2 exomes
AF:
0.00581
AC:
1459
AN:
251334
AF XY:
0.00608
show subpopulations
Gnomad AFR exome
AF:
0.00154
Gnomad AMR exome
AF:
0.00315
Gnomad ASJ exome
AF:
0.0149
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00296
Gnomad NFE exome
AF:
0.00837
Gnomad OTH exome
AF:
0.0106
GnomAD4 exome
AF:
0.00849
AC:
12394
AN:
1459236
Hom.:
73
Cov.:
30
AF XY:
0.00829
AC XY:
6017
AN XY:
726094
show subpopulations
African (AFR)
AF:
0.00126
AC:
42
AN:
33426
American (AMR)
AF:
0.00335
AC:
150
AN:
44712
Ashkenazi Jewish (ASJ)
AF:
0.0146
AC:
381
AN:
26080
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39656
South Asian (SAS)
AF:
0.00326
AC:
281
AN:
86226
European-Finnish (FIN)
AF:
0.00302
AC:
161
AN:
53380
Middle Eastern (MID)
AF:
0.0118
AC:
68
AN:
5760
European-Non Finnish (NFE)
AF:
0.00956
AC:
10607
AN:
1109718
Other (OTH)
AF:
0.0117
AC:
704
AN:
60278
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.415
Heterozygous variant carriers
0
551
1102
1652
2203
2754
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
408
816
1224
1632
2040
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00547
AC:
833
AN:
152300
Hom.:
5
Cov.:
32
AF XY:
0.00506
AC XY:
377
AN XY:
74468
show subpopulations
African (AFR)
AF:
0.00217
AC:
90
AN:
41564
American (AMR)
AF:
0.00314
AC:
48
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.0127
AC:
44
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5190
South Asian (SAS)
AF:
0.00290
AC:
14
AN:
4820
European-Finnish (FIN)
AF:
0.00254
AC:
27
AN:
10618
Middle Eastern (MID)
AF:
0.0170
AC:
5
AN:
294
European-Non Finnish (NFE)
AF:
0.00866
AC:
589
AN:
68028
Other (OTH)
AF:
0.00757
AC:
16
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
40
80
120
160
200
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00856
Hom.:
3
Bravo
AF:
0.00542
Asia WGS
AF:
0.00115
AC:
4
AN:
3478
EpiCase
AF:
0.00971
EpiControl
AF:
0.00877

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
7
not specified (7)
-
-
4
not provided (4)
-
-
1
Congenital muscular dystrophy due to partial LAMA2 deficiency (1)
-
-
1
LAMA2-related muscular dystrophy (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.46
CADD
Benign
14
DANN
Benign
0.85
PhyloP100
1.7
Mutation Taster
=90/10
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.88
dbscSNV1_RF
Benign
0.57
SpliceAI score (max)
0.060
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs41285288; hg19: chr6-129670438; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.